flow trial semaglutide kidney outcomes 2024 nejm hazard ratio clinical (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators ADA 24: FLOW Trial: Kidney

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes

The focus goes beyond the scale to support metabolic health, sustainable habits, and long-term weight management

Lipo-B Trim works by boosting your livers fat-burning metabolism, increasing natural energy levels, and accelerating recovery, making it an excellent standalone option or a powerful complement to Semaglutide

For example, they might advise you to drink more water to help manage dry mouth caused by Benadryl or to eat smaller meals to reduce the digestive effects of Semaglutide

Strength training supports mental health too Many people start GLP-1 medication to address physical health concerns, but they often stick with their new habits because of how it makes them feel not just physically, but mentally